These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29186)

  • 21. Similarities between the binding of 3H-piflutixol and 3H-flupentixol to rat striatal dopamine receptors in vitro.
    Hyttel J
    Life Sci; 1981 Feb; 28(5):563-9. PubMed ID: 6111013
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparative study of [3H]haloperidol and [3H]spiroperidol binding to receptors on rat cerebral membranes.
    Howlett DR; Nahorski SR
    FEBS Lett; 1978 Mar; 87(1):152-6. PubMed ID: 631328
    [No Abstract]   [Full Text] [Related]  

  • 23. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ; Tarazi FI; Creese I
    J Pharmacol Exp Ther; 1997 Feb; 280(2):561-9. PubMed ID: 9023264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of typical and atypical neuroleptics on alpha-noradrenergic and dopaminergic post synaptic receptors.
    Le Fur G; Burgevin MC; Malgouris C; Uzan A
    Neuropharmacology; 1979 Jul; 18(7):591-4. PubMed ID: 40153
    [No Abstract]   [Full Text] [Related]  

  • 25. Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum.
    Hess EJ; Battaglia G; Norman AB; Iorio LC; Creese I
    Eur J Pharmacol; 1986 Feb; 121(1):31-8. PubMed ID: 2869957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of tolamolol and other beta-adrenoceptor blocking drugs on [3H]haloperidol binding to rat striatal membrane preparations.
    Bremner RM; Greengrass PM; Morville M; Blackburn KJ
    J Pharm Pharmacol; 1978 Jun; 30(6):388-90. PubMed ID: 26777
    [No Abstract]   [Full Text] [Related]  

  • 27. Differential effects of haloperidol decanoate, a long-acting neuroleptic, in behavioral and biochemical tests.
    Oka M; Karasawa T; Ochi Y; Asano K; Terauchi Y; Kadokawa T
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):289-302. PubMed ID: 4062440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of repeated treatment with neuroleptics on dopamine metabolism in cell bodies and terminals of dopaminergic systems in the rat brain.
    Scatton B
    Adv Biochem Psychopharmacol; 1980; 24():31-6. PubMed ID: 6105783
    [No Abstract]   [Full Text] [Related]  

  • 29. 3-Methoxytyramine and different neuroleptics: dissociation from HVA and DOPAC.
    Groppetti A; Parenti M; Galli CL; Bugatti A; Cattabeni F; Di Giulio AM; Racagni G
    Life Sci; 1978 Oct; 23(17-18):1763-8. PubMed ID: 31531
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo.
    Ichikawa J; Meltzer HY
    Brain Res; 1992 Mar; 574(1-2):98-104. PubMed ID: 1379112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [3H]Haloperidol labels brain dopamine receptors after its injection into the internal carotid artery of the rat.
    D'Ambrosio A; Zivkovic B; Bartholini G
    Brain Res; 1982 Apr; 238(2):470-4. PubMed ID: 7093669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of amfonelic acid on the haloperidol- and clozapine-induced increase in extracellular DOPAC in the nucleus accumbens and the striatum.
    Rivest R; Marsden CA
    Synapse; 1992 Jan; 10(1):71-8. PubMed ID: 1371367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acute and chronic effects of carpipramine, clozapine, haloperidol and sulpiride on the metabolism of biogenic amines in the rat brain (author's transl)].
    von Stralendorff B; Ackenheil M; Zimmermann J
    Arzneimittelforschung; 1976; 26(6):1096-8. PubMed ID: 9108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain receptors for dopamine and neuroleptics.
    Seeman P; Titeler M; Tedesco J; Weinreich P; Sinclair D
    Adv Biochem Psychopharmacol; 1978; 19():167-76. PubMed ID: 29446
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study.
    Morissette M; Lévesque D; Di Paolo T
    Mol Pharmacol; 1992 Sep; 42(3):480-8. PubMed ID: 1357544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of some isoquinoline alkaloids on monoamines in the rat brain].
    Liu GQ; Jiang Y; Peng G; Ibrahim ; Zhou LQ
    Yao Xue Xue Bao; 1985 Aug; 20(8):566-70. PubMed ID: 2870602
    [No Abstract]   [Full Text] [Related]  

  • 37. Acute and chronic effects of neuroleptics and acute effects of apomorphine and amphetamine on dopamine turnover in corpus striatum and substantia nigra of the rat brain.
    Nicolaou NM
    Eur J Pharmacol; 1980 Jun; 64(2-3):123-32. PubMed ID: 6105080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of haloperidol and apomorphine treatment on dopamine receptors in pituitary and striatum.
    Friend WC; Brown GM; Jawahir G; Lee T; Seeman P
    Am J Psychiatry; 1978 Jul; 135(7):839-41. PubMed ID: 665797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of carbidine, sulpiride and haloperidol on levels of monoamines and their metabolites in the brain structures of rats].
    Miroshnichenko II; Kudrin VS; Raevskiĭ KS
    Farmakol Toksikol; 1988; 51(2):26-9. PubMed ID: 2897932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo occupancy of dopamine receptors by antipsychotic drugs.
    Meltzer HY; Stockmeier CA
    Arch Gen Psychiatry; 1992 Jul; 49(7):588-9. PubMed ID: 1352678
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.